Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acasti Pharma Inc
ACST
Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the...
brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(63)
•••
hydrocarbss
X
View Profile
View Bullboard History
Post by
hydrocarbss
on Jun 29, 2020 12:30pm
TG 'Normalization'
TG 'Normalization', if I follow this line of thought correctly the test subject's TG levels in the placebo arm only, just suddenly and quite mysteriously dropped to normal levels.
...more
(8)
•••
Whatsastockdad
X
View Profile
View Bullboard History
Comment by
Whatsastockdad
on Jun 29, 2020 12:23pm
RE:RE:UP UP AND UP!!!
Lets just hope it rises, im a fan of this and hope it gets some soild volume within this week! GLTA
Silvercorp to Acquire Adventus, Creating a Diversified Mining Company
posted May 02, 2024 9:00am by
Adventus Mining Corp.
-
|
Under the terms of the Arrangement Agreement, each holder of the common shares of Adventus will receive 0.1015 of one Silvercorp common share in exchange for each Adventus Share at the effective time of the Transaction. The Exchange Ratio implies consideration of C$0.50 per Adventus Share ...read more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 12:23pm
RE:Capre Works ! this is the bottom line
Trilogy 2 will push this to finish line shortly. CAPRE is most potent and mose effective medication for TG on the market and you don't need to have it with special diet. Plus the
...more
(52)
•••
Francine01
X
View Profile
View Bullboard History
Post by
Francine01
on Jun 29, 2020 12:15pm
Capre Works ! this is the bottom line
Same conclusion. I was a bit nervous before reading the PR, but the bottom line is that drug works : 1) The placebo affect is unfortanate and need to be understand, but when a drug reduce HTG
...more
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Post by
Danny1082Man
on Jun 29, 2020 12:05pm
NCEP Diet
Adding strict adherence to the NCEP in this study was a first for any TG redux study and is the main culprit causing the overall drop in both arms. Just didn't realize how strictly all the
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 12:03pm
RE:UP UP AND UP!!!
Yes, because people who "understand" are buying here. And people who don't know anything are just making noise. It's a nice gift here to buy at these levels. I
...more
(8)
•••
Whatsastockdad
X
View Profile
View Bullboard History
Post by
Whatsastockdad
on Jun 29, 2020 11:58am
UP UP AND UP!!!
Finally, some postive movement!
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Post by
Rosmorduc
on Jun 29, 2020 11:25am
Slowly adding more here....why you ask?
Because I analyzed the data profoundly this morning and there is no other conclusion to draw than....CAPRE works EXTREMELY WELL!!!
(8)
•••
Whatsastockdad
X
View Profile
View Bullboard History
Comment by
Whatsastockdad
on Jun 29, 2020 10:58am
RE:Rating change
1 to 2***
(8)
•••
Whatsastockdad
X
View Profile
View Bullboard History
Post by
Whatsastockdad
on Jun 29, 2020 10:57am
Rating change
2 to 3! - Morningstar Quant
(6)
•••
Ryeman40
X
View Profile
View Bullboard History
Post by
Ryeman40
on Jun 29, 2020 10:53am
Changes
Acasti is conducting further post hoc analysis based on fda feedback of Trilogy1. Acasti is now finalizing statistical analysis plan for Trilogy2 which they plan to submit to the fda by end of july
...more
(1849)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 29, 2020 10:50am
RE:RE:News
The 5 bad sites must have really messed something up..... The pre-randomization reduction in TGs across all subjects in TRILOGY 1 was about 20%, with 25% of all subjects experiencing a reduction
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 10:41am
RE:RE:News
We won't know unless the company clarifies. I'm sure they have all the answers. The independant auditor clearly came to the conclusion that something went astray.
(1849)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 29, 2020 10:32am
RE:News
I wish they had given some theories as to why there was an unusual TG normalization prior to start of trial. Did patients change their eating/exercise habits between the time they were told they
...more
(18)
•••
EternalPonzi
X
View Profile
View Bullboard History
Comment by
EternalPonzi
on Jun 29, 2020 10:29am
RE:RE:RE:RE:News
Let us hope that is the case, but this still may not satisfy requirements to file NDA. This 'normalization' issue should never have been allowed to happen in the first place. Whose fault is
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results